A Call for Transparency, Improved Reporting and Interpretation of Trials Using Surrogate Endpoints in Cardiac Electrophysiology

By sjmartinez • March 2, 2025

Tereshchenko LG, Manyara AM, Ciani O, Sodeke SO, Bradford CN, Santangeli P, Kapadia SR, Wazni O, Narayan SM, Chugh SS, Bilchick K, Huizar JF, Vaseghi M, Chung MK, Ellenbogen KA, Taylor RS. A Call for Transparency, Improved Reporting and Interpretation of Trials Using Surrogate Endpoints in Cardiac Electrophysiology. Heart Rhythm. 2025 Feb 26:S1547-5271(25)00209-7. doi: 10.1016/j.hrthm.2025.02.038. Epub ahead of print. PMID: 40021073.

Tags: Biomarker, Cardiology/Epi, Checklist, Clinical Trial, Outcome, Publications, Randomized Controlled Trial, Research design, standards, surrogate endpoint, surrogate marker

Toward Non-Invasive MR-Based Target Delineation for Ventricular Tachycardia Stereotactic Radiotherapy: Development of a 3D Wideband LGE MRI Technique

Dong H, Shih SF, Han F, Chin RK, Hayase JH, Bradfield JS, Bedayat A, Finn JP, Cao M, Zhong X. Toward Non-Invasive MR-Based Target Delineation[...]

Incremental Prognostic Value of Subendocardial Myocardial Flow Reserve in Patients With Normal Perfusion

Lopez DM, Brown JM, Divakaran S, Huck DM, Weber BN, Hainer J, Carre S, Lemley M, Ramirez G, Shanbhag A, Kavanagh P, Liang JX, Blankstein[...]

Body composition changes during cardiac rehabilitation and long-term cardiovascular outcomes in patients with coronary artery disease

Kumar A, Van C, Shahrvini T, Srikanthan P, Horwich TB. Body composition changes during cardiac rehabilitation and long-term cardiovascular outcomes in patients with coronary artery[...]